http://www.ksag.org/files/
riverside
Permalink: http://www.diigo.com/09mih
A small company can now advance its psychedelic into Phase 3. Here’s why
that matters to other psychedelic biotechs.
-
GH Research’s stock rallied after saying the FDA lifted a hold on its
experimental depression treatment.
49 minutes ago
Posts
No comments:
Post a Comment